CD86 and neoplasm: In a proof of concept study in mice, the antitumoral activity of DNAhsp65 was correlated with increased percentages of activated lymphocyte (CD4/CD44hi, CD8/CD44hi) infiltration into the tumor mass, enhanced CD86 costimulatory molecule expression in APCs and CD8-T lymphocytes specific lysis.